Magnetic resonance imaging-related programmable ventriculoperitoneal shunt valve setting changes occur often.

Purpose: Patients with programmable ventriculoperitoneal (VP) shunt valves undergo multiple skull radiographs to evaluate for setting changes resulting from MRI. Our purpose was to determine the rates of inadvertent, MRI-related, programmable VP shunt valve setting changes.

Materials And Methods: In this retrospective cohort with a study period of January 2015-December 2018, we reviewed the pre- and post-MRI skull radiographs of patients with programmable VP shunts and collected the following data: Demographics, commercial type of the valve used, magnetic field strength of the MRI device used, and whether a setting change occurred.

Brain magnetic resonance imaging at 3 Tesla using BLADE compared with standard rectilinear data sampling.

Objectives: We sought to evaluate Periodically Rotated Overlapping ParallEL Lines with Enhanced Reconstruction (PROPELLER; BLADE) data acquisition in comparison with standard k-space sampling techniques for axial and sagittal brain imaging at 3 T regarding imaging artifacts.

Material And Methods: Forty patients who gave consent were included in a prospective comparison of standard and PROPELLER (BLADE) k-space sampling techniques. All examinations were performed at 3 T with comparison of standard T2-weighted fluid-attenuated inversion recovery (FLAIR) to PROPELLER T2-weighted FLAIR in the axial image orientation and standard T1-weighted gradient echo to PROPELLER T1-weighted FLAIR in the sagittal image orientation.

T1-weighted imaging of the brain at 3 tesla using a 2-dimensional spoiled gradient echo technique.

Rationale And Objectives: The objective of this study was to evaluate a 2-dimensional spoiled gradient echo (GRE) imaging approach using a very short in-phase TE for routine T1-weighted imaging of the brain at 3 T.

Materials And Methods: Patient examinations were compared from a 3 T magnetic resonance (MR) unit located immediately adjacent to a similarly equipped 1.5 T unit.

Methotrexate-induced toxic leukoencephalopathy.

Drug-induced leukoencephalopathy is a devastating adverse event that can cause significant morbidity and mortality. Risk factors include advanced age, administration of certain chemotherapies, presence of an Ommaya device, central nervous system malignancy, and most important, exposure to cranial radiation. A 73-year-old woman developed leukoencephalopathy 2 months after her last dose of intraventricular methotrexate.